Ocular tolerance and efficiency of two solutions applied to non-infectious blepharitis.
Sore
G
G
La Roche-Posay Pharmaceutical Laboratories, Asnières, France.
Rougier
A
A
Richard
A
A
Péricoi
M
M
D000287:Administration, Topical; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001252:Astringents / Q000008:administration & dosage / Q000627:therapeutic use*; D001762:Blepharitis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D012643:Selenium / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D019287:Zinc Sulfate / Q000008:administration & dosage / Q000627:therapeutic use*
D000975:Antioxidants; D001252:Astringents; D019287:Zinc Sulfate; D012643:Selenium